5612539 TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE‐BLIND, PLACEBO‐CONTROLLED PHASE 2A CROSSWALK‐C TRIAL EVALUATING THE EFFICACY OF CROVALIMAB AS ADJUNCT TREATMENT IN THE PREVENTION OF VASO‐OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD)
Callaghan, M., Ataga, K.I., De Franceschi, L., Minniti, C., Balachandran, N., Imbs, D.‐.C., Perretti, T., Ramos, J., Sostelly, A., Bartolucci, P.
Published in HemaSphere (01.04.2023)
Published in HemaSphere (01.04.2023)
Get full text
Journal Article
5610823 TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE‐BLIND, PLACEBO‐CONTROLLED PHASE 1B CROSSWALK‐A TRIAL EVALUATING THE SAFETY OF CROVALIMAB FOR THE MANAGEMENT OF ACUTE UNCOMPLICATED VASO‐OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD)
Bartolucci, P., Ataga, K.I., Callaghan, M., De Franceschi, L., Minniti, C., Alexandrou, A., Imbs, D.‐.C., Fox, R.P., Patel, H., Sostelly, A., Schimmel, J.
Published in HemaSphere (01.04.2023)
Published in HemaSphere (01.04.2023)
Get full text
Journal Article
Inhibition of OCT2, MATE1 and MATE2-K as a possible mechanism of drug interaction between pazopanib and cisplatin
Sauzay, C., White-Koning, M., Hennebelle, I., Deluche, T., Delmas, C., Imbs, D.C., Chatelut, E., Thomas, F.
Published in Pharmacological research (01.08.2016)
Published in Pharmacological research (01.08.2016)
Get full text
Journal Article